PharmaCureâ„¢ Corporation Revenue and Competitors

PharmaCure™ Corporation has created WoundCure™, a powerful FDA approved OTC broad spectrum topical antibiotic that kills all bacteria that is 99.99% effective against all known bacteria. WoundCure™ is a powerful FDA approved OTC broad spectrum topical antibiotic that is 99.99% effective against all known bacteria, including MRSA, Staph, Acinetobacter, and VRE. Our research suggests that this is the safest and most powerful topical antibiotic available. It is ideal for both clinical and home use. Essentially, Woundcare™ kills every bacteria that causes a skin infection including life-threatening, flesh-eating bacteria such as MRSA. Not only has it been 99.99% successful in killing every bacteria, its award winning patented dual-carrier technology makes it virtually impossible for bacteria to become resistant to the antibiotic. WoundCure's™ active ingredient received the Bronze Award for 2012 Best New Pharmaceutical Product at the 25th Annual Edison Awards in New York City, and was named the winner of the Drug Store News Best New Product award. This recognition was by vote of key pharmacy industry decision makers at the ECRM® Marketgate™ 2012 meetings held in Charlotte, N.C.